Information Provided By: 
Fly News Breaks for September 22, 2015
INGN
Sep 22, 2015 | 08:29 EDT
Stifel increased its price target on Inogen after meeting with the company's management. The firm thinks that the company will benefit from the transition of oxygen therapy to portable concentrators, since it is the market leader in the latter category. The firm says Inogen's approach to portable concentrators saves money ,which should enable it to gain momentum over the next five years. The firm keeps a Buy rating on the shares.
News For INGN From the Last 2 Days
There are no results for your query INGN
